bendamustine hydrochloride has been researched along with Graft-Versus-Host Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 6 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Husnain, M; Katsanis, E; Khurana, S; Kovacs, K; Roe, DJ; Simpson, RJ; Stea, B; Truscott, L | 1 |
| Afanasyev, B; Beynarovich, A; Borzenkova, E; Kondakova, E; Kozlov, A; Kulagin, A; Lepik, K; Mikhailova, N; Moiseev, I; Pirogova, O; Stelmakh, L; Volkov, N; Zalyalov, Y; Zubarovskaya, L | 1 |
| Cracchiolo, MJ; Davini, DW; Gilman, KE; Katsanis, E; Matiatos, AP; Simpson, RJ | 1 |
| Hoffman, EA; Katsanis, E; Kummet, N; Molina, MS; Simpson, RJ; Stokes, J; Zeng, Y | 1 |
| Eremija, J; Hoffman, EA; Katsanis, E; Molina, MS; Simpson, RJ; Stokes, J; Zeng, Y | 1 |
| Baker, F; Hoffman, EA; Katsanis, E; Kummet, N; Molina, MS; Simpson, RJ; Smith, KA; Stokes, J; Zúñiga, TM | 1 |
| Katsanis, E; Koza, S; Sapp, LN; Stea, B; Varner, N; Zeng, Y | 1 |
| Eremija, J; Hoffman, EA; Katsanis, E; Larmonier, N; Molina, MS; Stokes, J; Zeng, Y | 1 |
| Ahmed, S; Alousi, A; Anderlini, P; Bassett, RL; Ciurea, S; Gulbis, A; Jabbour, E; Khouri, IF; Korbling, M; Oran, B; Popat, UR; Rondon, G; Turturro, F; Wei, W | 1 |
| Hoffman, EA; Katsanis, E; Larmonier, N; Stokes, J; Zeng, Y | 1 |
| Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N | 1 |
3 trial(s) available for bendamustine hydrochloride and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Feasibility and Efficacy of Partially Replacing Post-Transplantation Cyclophosphamide with Bendamustine in Pediatric and Young Adult Patients Undergoing Haploidentical Bone Marrow Transplantation.
Topics: Adolescent; Bendamustine Hydrochloride; Bone Marrow Transplantation; Child; Cyclophosphamide; Ethnicity; Feasibility Studies; Graft vs Host Disease; Humans; Minority Groups; Neoplasm Recurrence, Local; Young Adult | 2022 |
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide/Bendamustine in Pediatric and Young Adult Patients with Hematologic Malignancies.
Topics: Adolescent; Adult; Allografts; Bendamustine Hydrochloride; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Transplantation Conditioning; Transplantation, Haploidentical; Unrelated Donors; Young Adult | 2018 |
BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Bendamustine Hydrochloride; Combined Modality Therapy; Drug Combinations; Female; Graft vs Host Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Middle Aged; Nitrogen Mustard Compounds; Recurrence; Rituximab; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2014 |
8 other study(ies) available for bendamustine hydrochloride and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine-bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma.
Topics: Adult; Bendamustine Hydrochloride; Cyclophosphamide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2022 |
Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-disease.
Topics: Animals; Bendamustine Hydrochloride; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Leukocytes, Mononuclear; Mice | 2022 |
Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia.
Topics: Animals; Bendamustine Hydrochloride; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; T-Lymphocytes; Transplantation Conditioning; Whole-Body Irradiation | 2020 |
Bendamustine Conditioning Skews Murine Host DCs Toward Pre-cDC1s and Reduces GvHD Independently of Batf3.
Topics: Allografts; Animals; Basic-Leucine Zipper Transcription Factors; Bendamustine Hydrochloride; Dendritic Cells; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Mice; Repressor Proteins; Transplantation Conditioning; Whole-Body Irradiation | 2020 |
Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death.
Topics: Animals; Apoptosis; Bendamustine Hydrochloride; CD4-Positive T-Lymphocytes; Dendritic Cells; Female; fms-Like Tyrosine Kinase 3; Graft vs Host Disease; Humans; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Transplantation Conditioning | 2021 |
Bendamustine with Total Body Irradiation Limits Murine Graft-versus-Host Disease in Part Through Effects on Myeloid-Derived Suppressor Cells.
Topics: Animals; Bendamustine Hydrochloride; Cell Count; Combined Modality Therapy; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Mice; Myeloid-Derived Suppressor Cells; Transplantation Conditioning; Whole-Body Irradiation | 2019 |
Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.
Topics: Animals; Bendamustine Hydrochloride; Bone Marrow Transplantation; Cyclophosphamide; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility; Immunosuppression Therapy; Mice; Transplantation, Homologous | 2016 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult | 2013 |